January 30, 2013

H1N1 Flu Vaccines Safe During Pregnancy

By Logan Lafferty


The Norwegian study — supported by the Norwegian Institute of Public Health and the U.S. National Institutes of Health — involved a slightly different H1N1 vaccine from that used in the USA, says Gregory Poland, a professor and vaccine researcher at the Mayo Clinic in Minnesota. Norwegians added an adjuvant to their vaccine, which is intended to produce a stronger immune response.

New Parent magazine


Tags: adjuvant, Dr. Gregory Poland, H1N1, immune response, Immunology, Infectious Diseases, International, Mayo Clinic Rochester, New Parent Magazine, Norwegian Institute of Public Health, Research, U.S. National Institutes of Health, vaccine

Contact Us · Privacy Policy